Iodipamide
Cholografin, Sinografin (iodipamide) is a small molecule pharmaceutical. Iodipamide was first approved as Sinografin on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diatrizoate meglumine
+
Iodipamide meglumine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SINOGRAFIN | Bracco Diagnostics | N-011324 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Iodipamide meglumine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CHOLOGRAFIN MEGLUMINE | Bracco Diagnostics | N-009321 DISCN | 1982-01-01 | 2 products |
Hide discontinued
Iodipamide sodium
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CHOLOGRAFIN SODIUM | Bracco Diagnostics | N-009321 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Surgical wound infection | D013530 | — | — | — | 3 | 1 | 4 | ||
| Healthy volunteers/patients | — | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Replacement arthroplasty hip | D019644 | — | — | — | — | 1 | 1 | ||
| Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | 1 | |
| Drainage | D004322 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | IODIPAMIDE |
| INN | adipiodone |
| Description | Adipiodone is an organoiodine compound that is 3-amino-2,4,6-triiodobenzoic acid in which one of the amino hydrogens is substituted by a 6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl group. It is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. It has a role as a radioopaque medium. It is an organoiodine compound, a member of benzoic acids and a secondary carboxamide. It is a conjugate acid of an adipiodone(2-). |
| Classification | Small molecule |
| Drug class | iodine-containing contrast media; diuretics (sulfamoylbenzoic acid derivatives) |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I |
Identifiers
| PDB | — |
| CAS-ID | 606-17-7 |
| RxCUI | 5936 |
| ChEMBL ID | CHEMBL1165268 |
| ChEBI ID | — |
| PubChem CID | 3739 |
| DrugBank | DB04711 |
| UNII ID | TKQ858A3VW (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 163 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
169 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more